Finance

Lists
603739:SHA
Qingdao Vland Biotech INC
CNÂ¥11.75
-0.84%
(-0.10) 1D
Nov 5, 9:25:01 AM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 603739...
Open
CNÂ¥11.75
High
CNÂ¥11.75
Low
CNÂ¥11.75
Mkt. cap
2.92B
Avg. vol.
6.84M
Volume
9.70K
Dividend
0.85%
Quarterly dividend
CNÂ¥0.03
Ex-dividend date
May 29, 2026
P/E ratio
41.91
52-wk high
CNÂ¥18.41
52-wk low
CNÂ¥10.68
EPS
CNÂ¥0.28
No. of employees
2K
Open
CNÂ¥11.75
High
CNÂ¥11.75
Low
CNÂ¥11.75
Mkt. cap
2.92B
Avg. vol.
6.84M
Volume
9.70K
Dividend
0.85%
Quarterly dividend
CNÂ¥0.03
Ex-dividend date
May 29, 2026
P/E ratio
41.91
52-wk high
CNÂ¥18.41
52-wk low
CNÂ¥10.68
EPS
CNÂ¥0.28
No. of employees
2K
News stories
From web sources and news partners
About Qingdao Vland Biotech INC
CEO-
Employees1.52K
FoundedFeb 23, 2005
Headquarters-
SectorBiotechnology
Industry-
Websitevlandgroup.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
350.33M
345.05M
364.57M
387.16M
Cost of goods sold
196.37M
192.44M
205.47M
223.83M
Cost of revenue
196.37M
192.44M
205.47M
223.83M
Research and development expenses
38.97M
30.17M
31.87M
31.77M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
94.78M
87.70M
91.50M
94.50M
Operating expense
161.80M
124.11M
129.75M
107.64M
Total operating expenses
358.18M
316.55M
335.22M
331.47M
Operating income
-7.84M
28.50M
29.35M
55.68M
Other non operating income
-226.95K
584.70K
-1.93M
-19.30M
EBT including unusual items
15.32M
32.23M
36.61M
32.59M
EBT excluding unusual items
-14.43M
26.98M
21.44M
46.55M
Income tax expense
786.41K
6.78M
8.72M
844.92K
Effective tax rate
5.13%
21.03%
23.83%
2.59%
Other operating expenses
24.95M
4.07M
4.20M
-14.27M
Net income
8.03M
17.87M
20.69M
24.34M
Net profit margin
2.29%
5.18%
5.68%
6.29%
Earnings per share
-
-
-
-
Interest and investment income
177.29K
3.32M
-
8.64M
Interest expense
-5.59M
-5.42M
-4.46M
-
Net interest expenses
-5.41M
-2.11M
-4.46M
8.64M
Depreciation and amortization charges
-
-
-
-
EBITDA
21.14M
57.49M
56.49M
84.67M
Gain or loss from assets sale
-470.74K
-
-40.68K
40.68K
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps